Volpi A - Search Results

1

Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancers.

Riccobon A, Zoli W, Capucci A, Volpi A, Vasini M, Bonaguri C, Flamini E, Ravaioli A, Amadori D. Riccobon A, et al. Among authors: volpi a. Tumori. 1988 Apr 30;74(2):167-70. doi: 10.1177/030089168807400208. Tumori. 1988. PMID: 3285555

2

An efficient method for culturing human breast epithelium: analysis of results.

Volpi A, Savini S, Zoli W, Vasini M, Morgagni S, Amadori A, Volpi R, Amadori D. Volpi A, et al. Among authors: volpi r. Tumori. 1991 Dec 31;77(6):460-4. doi: 10.1177/030089169107700602. Tumori. 1991. PMID: 1803709

3

An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and on 116 recurrences.

Zoli W, Volpi A, Bonaguri C, Riccobon A, Savini S, Brizio R, Saragoni A, Medri L, Marra GA, Amadori D. Zoli W, et al. Among authors: volpi a. Breast Cancer Res Treat. 1991 Jan-Feb;17(3):231-8. doi: 10.1007/BF01806372. Breast Cancer Res Treat. 1991. PMID: 2039842

4

[Cytosol CEA: a prognosis factor in breast carcinoma? (personal experience with 76 cases)].

Amadori D, Frassineti L, Riccobon A, Volpi A, Vasini M, Nanni O, Zoli W, Pallotti G. Amadori D, et al. Among authors: volpi a. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):25-6. J Nucl Med Allied Sci. 1990. PMID: 2092127 Italian. No abstract available.

5

[Relationship between cytosol CEA and clinico-pathologic and biologic parameters in 167 cases if primary carcinoma of the breast].

Riccobon A, Frassineti L, Vasini M, Volpi A, Pallotti G, Flamini E, Magni E, Nunziatini R, Amadori D. Riccobon A, et al. Among authors: volpi a. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):27-8. J Nucl Med Allied Sci. 1990. PMID: 2092130 Italian. No abstract available.

6

Tumor microvessel density and prognosis in node-negative breast cancer.

Medri L, Nanni O, Volpi A, Scarpi E, Dubini A, Riccobon A, Becciolini A, Bianchi S, Amadori D. Medri L, et al. Among authors: volpi a. Int J Cancer. 2000 Jan 20;89(1):74-80. Int J Cancer. 2000. PMID: 10719734

7

Feasibility of a cell kinetic-based adjuvant chemotherapy trial in axillary node-negative breast cancer.

Volpi A, Nanni O, Vecci AM, Naldi S, Bernardi L, Marri L, Fedeli SL, Serra P, Amadori D. Volpi A, et al. Tumori. 2000 Mar-Apr;86(2):142-8. doi: 10.1177/030089160008600207. Tumori. 2000. PMID: 10855852 Clinical Trial.

8

Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study.

Volpi A, De Paola F, Nanni O, Granato AM, Bajorko P, Becciolini A, Scarpi E, Riccobon A, Balzi M, Amadori D. Volpi A, et al. Breast Cancer Res Treat. 2000 Oct;63(3):181-92. doi: 10.1023/a:1006464426977. Breast Cancer Res Treat. 2000. PMID: 11110052

9

In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.

Savini S, Zoli W, Nanni O, Volpi A, Frassineti GL, Magni E, Flamigni A, Amadori A, Amadori D. Savini S, et al. Among authors: volpi a. Breast Cancer Res Treat. 1992;24(1):27-34. doi: 10.1007/BF01832355. Breast Cancer Res Treat. 1992. PMID: 1463869

10

Clinical relevance of cell kinetics in breast cancer.

Amadori D, Volpi A, Callea A, Amaducci L, Morgagni S, Magni E, Nanni O. Amadori D, et al. Among authors: volpi a. Ann N Y Acad Sci. 1993 Nov 30;698:186-92. doi: 10.1111/j.1749-6632.1993.tb17208.x. Ann N Y Acad Sci. 1993. PMID: 8279756 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters